Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Long-Term Outcome of Differentiated Thyroid Cancer Patients-Fifty Years of Croatian Thyroid Disease Referral Centre Experience (CROSBI ID 308067)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Jukić, Tomislav ; Blažeković, Ivan ; Franceschi, Maja ; Petranović Ovčariček, Petra ; Bosak Butković, Marija ; Dabelić, Nina ; Granić, Roko ; Punda, Marija ; Sonicki, Zdenko ; Vagić, Davor et al. Long-Term Outcome of Differentiated Thyroid Cancer Patients-Fifty Years of Croatian Thyroid Disease Referral Centre Experience // Diagnostics, 12 (2022), 4; 866-880. doi: 10.3390/diagnostics12040866

Podaci o odgovornosti

Jukić, Tomislav ; Blažeković, Ivan ; Franceschi, Maja ; Petranović Ovčariček, Petra ; Bosak Butković, Marija ; Dabelić, Nina ; Granić, Roko ; Punda, Marija ; Sonicki, Zdenko ; Vagić, Davor ; Fröbe, Ana ; Kusić, Zvonko

engleski

Long-Term Outcome of Differentiated Thyroid Cancer Patients-Fifty Years of Croatian Thyroid Disease Referral Centre Experience

Background: Indolent nature but a high incidence of differentiated thyroid cancer (DTC) remains a challenge for optimizing patient care. Therefore, prognostic factors present valuable information for determining an adequate clinical approach. Methods: This study assessed prognostic features of 1167 papillary (PTC) and 215 follicular (FTC) thyroid cancer patients that had undergone surgery between 1962 and 2012, and were followed-up up to 50 years in a single institution, till April 2020. Age, gender, tumor size, presence of local and distant metastases at presentation, extrathyroidal extension, disease recurrence, and cancer-specific survival were evaluated. Results: In multivariate analysis, factors affecting the worse outcome were age (p = 0.005), tumor size (p = 0.006), and distant metastases (p = 0.001) in PTC, while extrathyroidal extension (p < 0.001), neck recurrence (p = 0.002), and distant metastases (p < 0.001) in FTC patients. Loco-regional recurrence rate was 6% for PTC and 4.7% for FTC patients, while distant metastases were detected in 4.2% PTC and 14.4% of FTC patients. The 10-year cancer- specific survival rates for PTC and FTC were 98.6% and 89.8%, respectively (p < 0.001). Conclusions: Negative prognostic factors, besides distant metastases, were older age and greater tumor size in PTC, and extrathyroidal extension and neck recurrence in FTC patients. The recurrence and mortality rates were very low.

differentiated thyroid cancer ; papillary ; follicular ; survival rates ; prognostic features ; recurrence ; follow-up

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

12 (4)

2022.

866-880

objavljeno

2075-4418

10.3390/diagnostics12040866

Povezanost rada

Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)

Poveznice
Indeksiranost